These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy. Arikan C; Kilic M; Tokat Y; Aydogdu S Transplant Proc; 2003 Dec; 35(8):3039-41. PubMed ID: 14697973 [TBL] [Abstract][Full Text] [Related]
6. Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. Charco R; Cantarell C; Vargas V; Capdevila L; Esteban R; Lázaro JL; Margarit C Transplant Proc; 1998 Jun; 30(4):1489. PubMed ID: 9636605 [No Abstract] [Full Text] [Related]
7. Acute tacrolimus overdose and treatment with phenytoin in liver transplant recipients. Karasu Z; Gurakar A; Carlson J; Pennington S; Kerwin B; Wright H; Nour B; Sebastian A J Okla State Med Assoc; 2001 Apr; 94(4):121-3. PubMed ID: 11392178 [TBL] [Abstract][Full Text] [Related]
8. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients. Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299 [TBL] [Abstract][Full Text] [Related]
10. Measurements of cardiac size, chamber volumes and valve orifices at autopsy. Hutchins GM; Anaya OA Johns Hopkins Med J; 1973 Aug; 133(2):96-106. PubMed ID: 4737243 [No Abstract] [Full Text] [Related]
11. Tacrolimus is effective in both dual and triple regimens after liver transplantation. Serrano J; García González M; Gómez M; Ortiz de Urbina J; López Cillero P; San Juan F; Parrilla P; Herrero JI Transplant Proc; 2002 Aug; 34(5):1529-30. PubMed ID: 12176469 [No Abstract] [Full Text] [Related]
12. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient. Cox TH; Baillie GM; Baliga P Pharmacotherapy; 1997; 17(6):1328-30. PubMed ID: 9399620 [TBL] [Abstract][Full Text] [Related]
13. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
15. Conversion to cyclosporine provides valuable rescue therapy for living donor adult liver transplant patients intolerant to tacrolimus: A single-center experience at the University of Tokyo. Tamura S; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Murai N; Makuuchi M Transplant Proc; 2004 Dec; 36(10):3242-4. PubMed ID: 15686738 [TBL] [Abstract][Full Text] [Related]
16. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients. Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359 [No Abstract] [Full Text] [Related]
17. Neoral is superior to FK 506 in liver transplantation. Levy GA Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293 [No Abstract] [Full Text] [Related]
18. Usefulness of the switch to tacrolimus in liver transplantation. González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653 [No Abstract] [Full Text] [Related]
19. Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. Rossi G; Reggiani P; Orsenigo R; Leoni L; Caccamo L; Doglia M; Gatti S; Maggi U; Paone G; Galmarini D; Fassati LR Transplant Proc; 1998 Jun; 30(4):1391-3. PubMed ID: 9636562 [No Abstract] [Full Text] [Related]